Active Wellness: Search, Learn & Order Drugs with ActiveMED

120mg , Capsule
Manufacture: TORRENT (PRIMA)
Rating:

Cost: ~~274.60~~
Discount 11%
244.39
Qty:
IN STOCK

Substitutes

Add Another Drug

Brand Name	Price	Pack	Save (₹)	Manufacturer
, Dilzem IV Injection Comp: (Diltiazem 5mg/ml )	19.54	5	-224.85	TORRENT (PRIMA)
, ONZEM Comp: (Diltiazem 90mg )	46.50	10	-197.89	NOVARTIS INDIA LTD
, Kaizem CD Comp: (Diltiazem 120mg )	70.50	2	-173.89	WOCKHARDT LTD
, Kaizem Comp: (Diltiazem 120mg )	75.25	7	-169.14	WOCKHARDT LTD
, Channel Comp: (Diltiazem 90mg )	116.00	10	-128.39	MICRO LABS LTD
, Dilzem CD Comp: (Diltiazem 90mg )	131.00	10	-113.39	TORRENT (PRIMA)
, Channel Comp: (Diltiazem 120mg )	138.00	10	-106.39	MICRO LABS LTD

Description

This calcium channel blocker has marked effects on heart as compared to blood vessel. It causes negative inotropic, chronotropic effects and decreases atrioventricular conduction. It is a modest vasodilator including that of coronary arteries.

Indications

Angina Pectoris

Side Effects

Bradycardia
Nausea
Oedema Ankle
Vomiting

Precautions

Liver Diseases
Kidney disease
Heart failure
Not recommended to children and age up to 18 years

Contraindications

A.V. Block
Bradycardia
Children
Elderly
Heart Block
Lactation
Myocardial Damage
Pregnancy
Reduce dose in Elderly patients

Interactions

Interact Type	Severity
Increases levels Digoxin
Increases levels Theophylline

Consumption Details

Route/Form	Dose	Age	Days
Oral/ Tablets	30-60 mg	Any All	Physician Advice

Safety in pregnancy

Diltiazem (Dilzem CD) falls in Category C

Pregnancy Category	Description
Category C	Either studies in animals have revealed adverse effects on the foetus (Teratogenic or Embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.
Category C	Either studies in animals have revealed adverse effects on the foetus (Teratogenic or Embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.

Diltiazem (Dilzem CD)